Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 591–600 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 591
- Medicine slug
- fenofibrate
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 136
- Source count
- 136
- Agreement rate
- 0.897059
- Recorded readings
20 hours
- Numeric value
- 20
- Unit
- hours
- Source records
- 122
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 122 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9be3ae3-6da9-47fd-bcfd-e561b9d585ca (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a504c42a-b629-4a21-a716-084962266b48 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e56492f-e2b1-4a07-b697-b59b3a0ac05e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa08cf6a-d306-4979-9b23-ac7febf4fd12 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0da6d56e-1ed6-437d-b88d-16b014d1889a (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:26f8f793-fb7a-4327-9441-d8737fe1ff11 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2e6711e9-782d-46bd-9447-6612fe7d0fe7 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05957860-eab3-4172-9877-455540d0c922 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration in a clinical setting.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d4e1d692-3c03-7406-ee06-7a6fb39ed3e7 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f958942-1504-40a1-8ad8-43df2c3f717e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate tablets.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41f0f514-1fa9-47a0-a085-a31354842f96 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3f4e5db8-5bfb-4b24-8465-9757cbaad2be (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e573b3f1-5a4c-4a19-9f0f-ee797b379a08 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a97ebf51-4f68-4426-9958-5c59f91b1d47 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6dd2e25c-aded-4499-e053-2991aa0a9d60 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate tablets.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d5c046b5-c3fd-4ef3-8245-c93796d4d880 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration in a clinical setting.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cc2038d-750e-42dc-b818-c5642cf6a5ad (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate tablets.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3f2b3a16-7735-487e-9a2c-e078a18df1bc (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f5df1da5-e390-42e4-e053-2a95a90aa8ea (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:954753e7-c8d4-487c-b2ad-f90dfb758a92 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration in a clinical setting.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4387adac-eea0-40c5-8111-1b70e0d98d7e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d8a93cb-6d66-4251-bb33-37982525ac09 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:44efa0d1-19d6-9696-e063-6394a90a068d (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9c60b43-dc61-4976-b31f-09c8f8a33138 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bbeae8e4-e06a-4c19-a1b9-f6143306dab9 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f443dd79-46da-4b02-8188-7417d39cf975 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42b1ad55-c449-4250-a666-bb36a6ff5b53 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e611f91-e351-9558-e063-6394a90ace17 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ddafb483-bae5-49bf-845d-67c29e6dc12d (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65ca643c-3b31-4e53-bc06-0e11418baf7d (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e949c068-bc7d-3038-e053-2a95a90aee00 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:215a5000-9f89-47d9-b2d5-94e13f5e1767 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58f0d475-24dc-4f93-aa40-3882b724b70f (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8f09ab1-74db-4123-b85a-6337dc2582a0 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate .
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66761695-8630-49ff-8264-965dee246437 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b79efcf4-6016-4a1f-b83f-be00baa25c21 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bdc2211e-6d65-1500-e053-2a95a90ab145 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b6e2a7-68d7-264d-e053-2a95a90aa9d1 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate .
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:39e61e9d-dda8-4989-a3dd-79545a5c9157 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:085109a6-f006-44f0-a170-980d8899a365 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate tablets.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b92fb19a-d0df-426e-e053-2995a90ab379 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65f5dcad-5073-4347-9ec9-e7f350b134c4 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:734f72a2-96f7-4480-9a87-c1ffd94b5f0b (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d26e21bf-6c54-437d-81fe-07220e450561 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8eee54d1-48ca-4704-93f3-0ac6fd7f464e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4cb6617c-f787-470f-81d8-0aba46df937f (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1da57e8c-3977-43e1-aa7e-229760203f7d (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd98e467-ecb3-463c-81d8-8b4d89159ab0 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2985c70d-e85d-483e-8d36-7a4b8454b038 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:125bbd7e-86a2-4209-90a5-ad353e572d1b (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:67a0cee0-79be-472a-a2a3-3aee2410b58b (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0865c177-b78a-318e-e063-6394a90a318a (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc9d1672-5f82-45a1-b862-859703b3dc37 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c579378-e00e-4802-b9d3-c062cf8bd9f4 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate tablets.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:283e754e-6ffa-4d6a-882f-9bbb3cbc8ca8 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42b1daf6-1f0e-4464-b160-7c10c492a570 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06870192-c92a-40c7-a619-efda0c006301 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45364845-c3b4-40a1-a677-82202ffaa5ad (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1f64796-6ba0-415c-a6a0-5456b21a7ed6 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0178ea2e-2c79-b97b-e063-6394a90ac145 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate .
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c810b16b-32e2-4d0c-aa28-bf1f62110757 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a5bc232c-ff27-f8b6-e053-2995a90ad399 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration in a clinical setting.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b6b5d74d-d418-4ada-8ccd-592b0f57b2ff (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:edace25a-3296-9ca7-dcb8-d0698f65840d (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bbffd586-f63a-4a84-bdfb-3e4a1df6449e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration offenofibrate .
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db3ac584-2c8e-4f69-b24c-96ddcca2c23f (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d34f9fa3-39ae-4b8e-8f29-0d5c655c50b5 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3db58c5c-b862-4871-b3f9-597aaeba56c4 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f3af845c-ce4e-4bf2-82e7-7753c9088645 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:00c2f942-e839-46fc-948a-f8e2fa79ccd1 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:84b2af1b-365e-4723-ac5f-bc826ec47772 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35ba17d9-0dd7-4f15-8f74-be5fd15f1917 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:882ee82a-3c56-4173-af42-68c3aadc8aa7 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df9f67d6-3cd9-4f44-8020-2d6ef53c30b5 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e7b79ab-9df0-4bbf-b7a4-a44aec203555 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate tablets.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e58c13a-8088-4fed-86cc-52530de5aa45 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c681270-fe04-4bd8-9fde-98e87ded9b83 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:556c4800-24f6-4237-8636-3211997cbb03 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3134b274-5dc0-cf90-e063-6294a90a252b (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration in a clinical setting.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:43aa7e51-443c-4ea0-abf2-f7d9378b3ba9 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fafbc0be-f0ba-4dcd-8aa5-89527bae5e84 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb400ea7-bbd8-440b-b8be-082121621408 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0c7070e-b3bb-4b5b-8a62-4e3136b5accc (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e69d844-5ded-46b6-8321-c420e8b37a63 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:38f43148-4ca0-402a-ba39-8ee5011a7907 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa9deae7-6cbf-4559-8130-b86b23b6d0ec (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate tablets.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ce403472-6c0c-4854-bb82-ba6539e1ae07 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration in a clinical setting.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f669f231-98b9-5014-e053-2a95a90a4e4c (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b448774-aebf-45fe-92f1-b8eca53cf09b (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f73a40ef-1513-4a07-a5a9-51efb30bf560 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d0cfddc-ace3-4187-8d94-d760d23d20b6 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration in a clinical setting.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b4447a1-8136-4258-b2c8-c5f9c1bcec92 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:07d47c02-ab29-4ba9-aea0-96ffbd70c0ef (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration in a clinical setting.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5a90e0a4-7892-462f-9776-037d23a93b10 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e9898d1-1fc0-b7c6-e053-2a95a90a65cd (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0b4e90dd-646b-afec-e063-6294a90a598e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f7590970-c54d-24e9-e053-6294a90ac400 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca09372a-3c75-47c9-80a3-e08dbe243bb4 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b11f1c74-23da-4273-b504-0a2ca22c4b5a (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b6c5ebd-a8bc-4502-8b66-f4e58914815b (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7e79d495-5d59-485e-b3c2-7c31ba044948 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f04cfe2a-1c06-4a7f-8149-7736a96e8f73 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:40ca5d88-6403-4c4b-ae7f-ae8cec4d9965 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:da2f0ba4-7c16-4fb0-bc1c-45540e8fefbf (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration in a clinical setting.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b9a6866c-9dbe-4419-bcad-52ec0127821f (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:84fcea7a-05ed-44c2-98fa-7e87b28d2261 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:573ffb90-61a7-4b2d-b191-13de6c01d19e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration in a clinical setting.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7cfa38f-b4db-40d3-8821-3f7c85e2727e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e8b9d1f5-0541-424f-b1d4-bef6381aa934 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration of fenofibrate tablets.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e7204052-02cf-4b38-835b-d8754c74b2cd (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration in a clinical setting.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b4488f4-bef6-408c-9fca-3e4aebceff9a (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration in a clinical setting.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0e240290-f11b-8cc4-e063-6294a90a74f0 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f937a176-3d3e-4dc6-a7d4-c1a4749c7a7f (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17edfb43-b708-45cc-9b48-54a4d453adac (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:968e7f57-1360-ba5a-e053-2995a90a206c (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7792d680-76ee-4146-9451-b16c40656cc1 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1fb3b66-cac9-49cd-a9f8-c4ce960f66e7 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d284236-c788-4e9e-8573-4d119e45d3b9 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration in a clinical setting.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba8e809e-f6b5-4ba8-9108-81cc82b14225 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2f46239-951d-fc0e-e053-2995a90ae979 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c740f57c-cac5-4526-a5a9-aaab65b1caf6 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily administration in a clinical setting.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7eb328d0-4e6f-4b24-ae85-68c2b3657569 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing.
23 hours
- Numeric value
- 23
- Unit
- hours
- Source records
- 12
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 12 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:338d03b2-c34e-6e24-e063-6394a90a3c39 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid from fenofibrate tablets is eliminated with a half-life of 23 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b67f389-55e8-466b-82bd-5ea992f630aa (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid from fenofibrate tablets is eliminated with a half-life of 23 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68024459-987a-9cf4-f539-4959093bc9f0 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 23 hours, allowing once daily administration of fenofibrate capsules.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3389b846-8926-3ad5-e063-6294a90aee39 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid from fenofibrate tablets is eliminated with a half-life of 23 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f5cee5c-ec55-4e9b-9d54-e7f2f052130e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 23 hours, allowing once daily administration of fenofibrate Metabolism Following oral administration, fenofibrate is rapidly hydrolyzed by esterases to the active metabolite, fenofibric acid; no unchanged fenofibrate is detected in plasma.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c3539e4-bc4a-8152-e063-6294a90ab55c (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid from fenofibrate tablets are eliminated with a half-life of 23 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2083f5d9-92f2-4c64-b996-fabbd6946ea0 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 23 hours, allowing once daily administration of fenofibrate Metabolism Following oral administration, fenofibrate is rapidly hydrolyzed by esterases to the active metabolite, fenofibric acid; no unchanged fenofibrate is detected in plasma.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:12ebf783-64df-4ffa-9e84-f8fdf4d245d4 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of 23 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65d8aefc-7ec2-4f62-9254-5f0070c58ac2 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibric acid from fenofibrate tablets are eliminated with a half-life of 23 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16ea8ce4-8c1c-4111-509e-86aa688d89a0 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibrate acid from fenofibrate is eliminated with a half-life of 23 hours, allowing once daily dosing. • Geriatrics: In elderly volunteers 77 to 87 years of age, the oral clearance of fenofibric acid following a single oral dose of fenofibrate was 1.2 L/h, which compares to 1.1 L/h in young adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37b25526-0bd0-4459-a4be-f3a6893506f9 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Fenofibrate acid is eliminated with a half-life of 23 hours, allowing once daily dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:24790a18-0291-4b88-a724-acac43b616ce (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of 23 hours, allowing once daily administration of Antara.
0.91 hours
- Numeric value
- 0.91
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78b789b9-854f-46b9-97f3-a48759a6ff89 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
In the same study, the half-life was observed to be 0.91 hours for the parent compound versus 16.76 hours for the metabolite.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3a69e15a-eda6-4a6e-8934-6881e4370521 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
In the same study, the half-life was observed to be 0.91 hours for the parent compound versus 16.76 hours for the metabolite.
Projected row 592
- Medicine slug
- fenofibrate
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 136
- Source count
- 136
- Agreement rate
- 1
- Recorded readings
99%
- Numeric value
- 99
- Unit
- %
- Source records
- 136
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 136 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9be3ae3-6da9-47fd-bcfd-e561b9d585ca (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a504c42a-b629-4a21-a716-084962266b48 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e56492f-e2b1-4a07-b697-b59b3a0ac05e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa08cf6a-d306-4979-9b23-ac7febf4fd12 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0da6d56e-1ed6-437d-b88d-16b014d1889a (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:26f8f793-fb7a-4327-9441-d8737fe1ff11 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2e6711e9-782d-46bd-9447-6612fe7d0fe7 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects. 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action The active moiety of fenofibrate is fenofibric acid.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05957860-eab3-4172-9877-455540d0c922 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:338d03b2-c34e-6e24-e063-6394a90a3c39 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d4e1d692-3c03-7406-ee06-7a6fb39ed3e7 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f958942-1504-40a1-8ad8-43df2c3f717e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41f0f514-1fa9-47a0-a085-a31354842f96 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3f4e5db8-5bfb-4b24-8465-9757cbaad2be (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e573b3f1-5a4c-4a19-9f0f-ee797b379a08 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a97ebf51-4f68-4426-9958-5c59f91b1d47 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6dd2e25c-aded-4499-e053-2991aa0a9d60 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d5c046b5-c3fd-4ef3-8245-c93796d4d880 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cc2038d-750e-42dc-b818-c5642cf6a5ad (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3f2b3a16-7735-487e-9a2c-e078a18df1bc (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f5df1da5-e390-42e4-e053-2a95a90aa8ea (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:954753e7-c8d4-487c-b2ad-f90dfb758a92 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4387adac-eea0-40c5-8111-1b70e0d98d7e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d8a93cb-6d66-4251-bb33-37982525ac09 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:44efa0d1-19d6-9696-e063-6394a90a068d (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9c60b43-dc61-4976-b31f-09c8f8a33138 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b67f389-55e8-466b-82bd-5ea992f630aa (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bbeae8e4-e06a-4c19-a1b9-f6143306dab9 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f443dd79-46da-4b02-8188-7417d39cf975 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42b1ad55-c449-4250-a666-bb36a6ff5b53 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e611f91-e351-9558-e063-6394a90ace17 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ddafb483-bae5-49bf-845d-67c29e6dc12d (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68024459-987a-9cf4-f539-4959093bc9f0 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65ca643c-3b31-4e53-bc06-0e11418baf7d (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e949c068-bc7d-3038-e053-2a95a90aee00 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects. 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action The active moiety of fenofibrate is fenofibric acid.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:215a5000-9f89-47d9-b2d5-94e13f5e1767 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58f0d475-24dc-4f93-aa40-3882b724b70f (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8f09ab1-74db-4123-b85a-6337dc2582a0 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66761695-8630-49ff-8264-965dee246437 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b79efcf4-6016-4a1f-b83f-be00baa25c21 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bdc2211e-6d65-1500-e053-2a95a90ab145 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b6e2a7-68d7-264d-e053-2a95a90aa9d1 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:39e61e9d-dda8-4989-a3dd-79545a5c9157 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3389b846-8926-3ad5-e063-6294a90aee39 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:085109a6-f006-44f0-a170-980d8899a365 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b92fb19a-d0df-426e-e053-2995a90ab379 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65f5dcad-5073-4347-9ec9-e7f350b134c4 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f5cee5c-ec55-4e9b-9d54-e7f2f052130e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:734f72a2-96f7-4480-9a87-c1ffd94b5f0b (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d26e21bf-6c54-437d-81fe-07220e450561 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8eee54d1-48ca-4704-93f3-0ac6fd7f464e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4cb6617c-f787-470f-81d8-0aba46df937f (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1da57e8c-3977-43e1-aa7e-229760203f7d (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd98e467-ecb3-463c-81d8-8b4d89159ab0 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2985c70d-e85d-483e-8d36-7a4b8454b038 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:125bbd7e-86a2-4209-90a5-ad353e572d1b (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:67a0cee0-79be-472a-a2a3-3aee2410b58b (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0865c177-b78a-318e-e063-6394a90a318a (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc9d1672-5f82-45a1-b862-859703b3dc37 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c579378-e00e-4802-b9d3-c062cf8bd9f4 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:283e754e-6ffa-4d6a-882f-9bbb3cbc8ca8 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42b1daf6-1f0e-4464-b160-7c10c492a570 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06870192-c92a-40c7-a619-efda0c006301 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45364845-c3b4-40a1-a677-82202ffaa5ad (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1f64796-6ba0-415c-a6a0-5456b21a7ed6 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0178ea2e-2c79-b97b-e063-6394a90ac145 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c810b16b-32e2-4d0c-aa28-bf1f62110757 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a5bc232c-ff27-f8b6-e053-2995a90ad399 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b6b5d74d-d418-4ada-8ccd-592b0f57b2ff (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:edace25a-3296-9ca7-dcb8-d0698f65840d (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bbffd586-f63a-4a84-bdfb-3e4a1df6449e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db3ac584-2c8e-4f69-b24c-96ddcca2c23f (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c3539e4-bc4a-8152-e063-6294a90ab55c (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d34f9fa3-39ae-4b8e-8f29-0d5c655c50b5 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3db58c5c-b862-4871-b3f9-597aaeba56c4 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f3af845c-ce4e-4bf2-82e7-7753c9088645 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:00c2f942-e839-46fc-948a-f8e2fa79ccd1 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:84b2af1b-365e-4723-ac5f-bc826ec47772 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35ba17d9-0dd7-4f15-8f74-be5fd15f1917 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:882ee82a-3c56-4173-af42-68c3aadc8aa7 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df9f67d6-3cd9-4f44-8020-2d6ef53c30b5 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78b789b9-854f-46b9-97f3-a48759a6ff89 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3a69e15a-eda6-4a6e-8934-6881e4370521 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e7b79ab-9df0-4bbf-b7a4-a44aec203555 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e58c13a-8088-4fed-86cc-52530de5aa45 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c681270-fe04-4bd8-9fde-98e87ded9b83 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:556c4800-24f6-4237-8636-3211997cbb03 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3134b274-5dc0-cf90-e063-6294a90a252b (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:43aa7e51-443c-4ea0-abf2-f7d9378b3ba9 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fafbc0be-f0ba-4dcd-8aa5-89527bae5e84 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb400ea7-bbd8-440b-b8be-082121621408 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0c7070e-b3bb-4b5b-8a62-4e3136b5accc (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e69d844-5ded-46b6-8321-c420e8b37a63 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:38f43148-4ca0-402a-ba39-8ee5011a7907 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa9deae7-6cbf-4559-8130-b86b23b6d0ec (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ce403472-6c0c-4854-bb82-ba6539e1ae07 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2083f5d9-92f2-4c64-b996-fabbd6946ea0 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f669f231-98b9-5014-e053-2a95a90a4e4c (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:12ebf783-64df-4ffa-9e84-f8fdf4d245d4 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b448774-aebf-45fe-92f1-b8eca53cf09b (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f73a40ef-1513-4a07-a5a9-51efb30bf560 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d0cfddc-ace3-4187-8d94-d760d23d20b6 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b4447a1-8136-4258-b2c8-c5f9c1bcec92 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:07d47c02-ab29-4ba9-aea0-96ffbd70c0ef (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65d8aefc-7ec2-4f62-9254-5f0070c58ac2 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5a90e0a4-7892-462f-9776-037d23a93b10 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e9898d1-1fc0-b7c6-e053-2a95a90a65cd (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0b4e90dd-646b-afec-e063-6294a90a598e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16ea8ce4-8c1c-4111-509e-86aa688d89a0 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects. • Metabolism: Following oral administration, fenofibrate is rapidly hydrolyzed by esterases to the active metabolite, fenofibric acid; no unchanged fenofibrate is detected in plasma.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f7590970-c54d-24e9-e053-6294a90ac400 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca09372a-3c75-47c9-80a3-e08dbe243bb4 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b11f1c74-23da-4273-b504-0a2ca22c4b5a (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b6c5ebd-a8bc-4502-8b66-f4e58914815b (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7e79d495-5d59-485e-b3c2-7c31ba044948 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f04cfe2a-1c06-4a7f-8149-7736a96e8f73 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:40ca5d88-6403-4c4b-ae7f-ae8cec4d9965 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:da2f0ba4-7c16-4fb0-bc1c-45540e8fefbf (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b9a6866c-9dbe-4419-bcad-52ec0127821f (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37b25526-0bd0-4459-a4be-f3a6893506f9 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:84fcea7a-05ed-44c2-98fa-7e87b28d2261 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:573ffb90-61a7-4b2d-b191-13de6c01d19e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7cfa38f-b4db-40d3-8821-3f7c85e2727e (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e8b9d1f5-0541-424f-b1d4-bef6381aa934 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e7204052-02cf-4b38-835b-d8754c74b2cd (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b4488f4-bef6-408c-9fca-3e4aebceff9a (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0e240290-f11b-8cc4-e063-6294a90a74f0 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f937a176-3d3e-4dc6-a7d4-c1a4749c7a7f (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17edfb43-b708-45cc-9b48-54a4d453adac (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:968e7f57-1360-ba5a-e053-2995a90a206c (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7792d680-76ee-4146-9451-b16c40656cc1 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1fb3b66-cac9-49cd-a9f8-c4ce960f66e7 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d284236-c788-4e9e-8573-4d119e45d3b9 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba8e809e-f6b5-4ba8-9108-81cc82b14225 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2f46239-951d-fc0e-e053-2995a90ae979 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c740f57c-cac5-4526-a5a9-aaab65b1caf6 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:24790a18-0291-4b88-a724-acac43b616ce (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7eb328d0-4e6f-4b24-ae85-68c2b3657569 (opens source in a new tab)
Fenofibrate label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and hyperlipidemic subjects.
Projected row 593
- Medicine slug
- fenofibric-acid
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 8
- Source count
- 8
- Agreement rate
- 1
- Recorded readings
81%
- Numeric value
- 81
- Unit
- %
- Source records
- 8
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 8 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8ffcb173-095a-4550-84f2-18959ad2aab8 (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
The absolute bioavailability of fenofibric acid is approximately 81%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c880d43a-fa8c-4f7a-a488-419bae7cc311 (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
The absolute bioavailability of fenofibric acid is approximately 81%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:302ffbf8-448e-4729-949f-40d457e30ab4 (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
The absolute bioavailability of fenofibric acid is approximately 81%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e73404c5-e0ee-48e9-8b09-7a00d7e18e6c (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
The absolute bioavailability of fenofibric acid is approximately 81%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:daa488be-f580-430c-a72c-80ac31bb3e40 (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
The absolute bioavailability of fenofibric acid is approximately 81%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9ad201de-fa62-4c49-bc61-ee09b9ba434c (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
The absolute bioavailability of fenofibric acid is approximately 81%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af225492-73b0-49bb-b32f-5399c3c3ec6d (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
The absolute bioavailability of fenofibric acid is approximately 81%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b9a3f97c-9e31-4a5f-822f-c9d45e394493 (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
The absolute bioavailability of fenofibric acid is approximately 81%.
Projected row 594
- Medicine slug
- fenofibric-acid
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 8
- Source count
- 8
- Agreement rate
- 1
- Recorded readings
20 hours
- Numeric value
- 20
- Unit
- hours
- Source records
- 8
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 8 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8ffcb173-095a-4550-84f2-18959ad2aab8 (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of approximately 20 hours, allowing once daily administration of fenofibric acid delayed-release capsules.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c880d43a-fa8c-4f7a-a488-419bae7cc311 (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of approximately 20 hours, allowing once daily administration of fenofibric acid delayed-release capsules.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:302ffbf8-448e-4729-949f-40d457e30ab4 (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of approximately 20 hours, allowing once daily administration of fenofibric acid delayed-release capsules.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e73404c5-e0ee-48e9-8b09-7a00d7e18e6c (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of approximately 20 hours, allowing once daily administration of fenofibric acid delayed-release capsules.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:daa488be-f580-430c-a72c-80ac31bb3e40 (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of approximately 20 hours, allowing once daily administration of fenofibric acid delayed-release capsules.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9ad201de-fa62-4c49-bc61-ee09b9ba434c (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of approximately 20 hours, allowing once daily administration of fenofibric acid delayed-release capsules.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af225492-73b0-49bb-b32f-5399c3c3ec6d (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
Elimination Fenofibric acid is eliminated with a half-life of approximately 20 hours, allowing once daily administration of fenofibric acid delayed-release capsules.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b9a3f97c-9e31-4a5f-822f-c9d45e394493 (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
Fenofibric acid is eliminated with a half-life of approximately 20 hours, allowing once daily administration of fenofibric acid delayed-release capsules. 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action The active moiety of fenofibric acid delayed-release capsule is fenofibric acid.
Projected row 595
- Medicine slug
- fenofibric-acid
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 8
- Source count
- 8
- Agreement rate
- 1
- Recorded readings
99%
- Numeric value
- 99
- Unit
- %
- Source records
- 8
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 8 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8ffcb173-095a-4550-84f2-18959ad2aab8 (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and dyslipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c880d43a-fa8c-4f7a-a488-419bae7cc311 (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
Serum protein binding is approximately 99% in normal and dyslipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:302ffbf8-448e-4729-949f-40d457e30ab4 (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
Serum protein binding is approximately 99% in normal and dyslipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e73404c5-e0ee-48e9-8b09-7a00d7e18e6c (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and dyslipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:daa488be-f580-430c-a72c-80ac31bb3e40 (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and dyslipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9ad201de-fa62-4c49-bc61-ee09b9ba434c (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and dyslipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af225492-73b0-49bb-b32f-5399c3c3ec6d (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
Serum protein binding was approximately 99% in normal and dyslipidemic subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b9a3f97c-9e31-4a5f-822f-c9d45e394493 (opens source in a new tab)
Fenofibric Acid label
Version not recorded · Effective date not recorded
Serum protein binding is approximately 99% in normal and dyslipidemic subjects.
Projected row 596
- Medicine slug
- fenoprofen
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 7
- Source count
- 7
- Agreement rate
- 1
- Recorded readings
3 hours
- Numeric value
- 3
- Unit
- hours
- Source records
- 7
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 7 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4aa38cca-9f8f-4ab6-8103-4f1f48801a43 (opens source in a new tab)
Fenoprofen label
Version not recorded · Effective date not recorded
Elimination Metabolism The plasma half-life is approximately 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ed1a69a-2375-4cc8-ac2f-1201d7e0b9d0 (opens source in a new tab)
Fenoprofen label
Version not recorded · Effective date not recorded
Elimination Metabolism The plasma half-life is approximately 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56b07659-1fd8-4c3e-e063-6294a90a8908 (opens source in a new tab)
Fenoprofen label
Version not recorded · Effective date not recorded
Elimination Metabolism The plasma half-life is approximately 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3daa336f-2acf-4109-a360-b1d30b192d41 (opens source in a new tab)
Fenoprofen label
Version not recorded · Effective date not recorded
Elimination Metabolism The plasma half-life is approximately 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d33ad329-1ca6-ac2e-e053-2995a90a15c5 (opens source in a new tab)
Fenoprofen label
Version not recorded · Effective date not recorded
Elimination Metabolism The plasma half-life is approximately 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d438989-6431-4c62-8f24-444475d423a3 (opens source in a new tab)
Fenoprofen label
Version not recorded · Effective date not recorded
Elimination Metabolism The plasma half-life is approximately 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b26c8351-a955-4685-adad-a7233db39d92 (opens source in a new tab)
Fenoprofen label
Version not recorded · Effective date not recorded
Elimination Metabolism The plasma half-life is approximately 3 hours.
Projected row 597
- Medicine slug
- fentanyl
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 13
- Source count
- 5
- Agreement rate
- 0.8
- Recorded readings
34 hours
- Numeric value
- 34
- Unit
- hours
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf02ffd0-cc5d-446b-b648-378f6885052f (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
A study conducted with the fentanyl transdermal system patch in elderly patients demonstrated that fentanyl pharmacokinetics did not differ significantly from young adult subjects, although peak serum concentrations tended to be lower and mean half-life values were prolonged to approximately 34 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:73897c38-e4ec-40bc-9f41-3359ee23a5a8 (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
A study conducted with the fentanyl transdermal system patch in elderly patients demonstrated that fentanyl pharmacokinetics did not differ significantly from young adult subjects, although peak serum concentrations tended to be lower and mean half-life values were prolonged to approximately 34 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:242759ef-cb6d-4e3e-9f8d-5e31efa1f289 (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
A study conducted with the fentanyl transdermal system patch in elderly patients demonstrated that fentanyl pharmacokinetics did not differ significantly from young adult subjects, although peak serum concentrations tended to be lower and mean half-life values were prolonged to approximately 34 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a2238e9-4b5d-c56d-8663-dd354ff9ae0c (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
A study conducted with the fentanyl transdermal system in elderly patients demonstrated that fentanyl pharmacokinetics did not differ significantly from young adult subjects, although peak serum concentrations tended to be lower and mean half-life values were prolonged to approximately 34 hours.
7 hours
- Numeric value
- 7
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78221eab-66fd-4cd8-9c81-af52eb83671c (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
The terminal elimination half-life after OTFC administration is about 7 hours.
Projected row 598
- Medicine slug
- fentanyl
- Compared field
- volumeOfDistribution
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 13
- Source count
- 13
- Agreement rate
- 0.692308
- Recorded readings
4 L/kg
- Numeric value
- 4
- Unit
- L/kg
- Source records
- 9
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 9 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78221eab-66fd-4cd8-9c81-af52eb83671c (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
The mean volume of distribution at steady state (Vss) was 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aacf276b-e133-4199-ad3f-67b894744c04 (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
The volume of distribution for fentanyl is 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bfa8018a-4cbc-434b-e09e-782872b0340a (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
The volume of distribution for fentanyl is 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58dcd3f7-e3d8-4929-a186-8f680a51ff11 (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
The volume of distribution for fentanyl is 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:38d0c14a-a0c1-44cc-a939-0304eb8037d6 (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
The volume of distribution for fentanyl is 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c10e465-4117-48ba-a454-23ccb7a3fcc7 (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
The volume of distribution for fentanyl is 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ce5db1c2-feb1-4ad2-847a-d02e865bd47e (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
The volume of distribution for fentanyl is 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ed25b2c-334e-4021-ada1-3396f07630dc (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
The volume of distribution for fentanyl is 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c5fcdcbd-1dd1-4ebf-aa0d-edfe845414b7 (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
The volume of distribution for fentanyl is 4 L/kg.
6 L/kg
- Numeric value
- 6
- Unit
- L/kg
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf02ffd0-cc5d-446b-b648-378f6885052f (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
The average volume of distribution for fentanyl is 6 L/kg (range 3-8;
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:73897c38-e4ec-40bc-9f41-3359ee23a5a8 (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
The average volume of distribution for fentanyl is 6 L/kg (range 3-8;
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:242759ef-cb6d-4e3e-9f8d-5e31efa1f289 (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
The average volume of distribution for fentanyl is 6 L/kg (range 3-8;
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a2238e9-4b5d-c56d-8663-dd354ff9ae0c (opens source in a new tab)
Fentanyl label
Version not recorded · Effective date not recorded
The average volume of distribution for fentanyl is 6 L/kg (range 3-8;
Projected row 599
- Medicine slug
- ferric
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 4
- Source count
- 3
- Agreement rate
- 1
- Recorded readings
45%
- Numeric value
- 45
- Unit
- %
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:314bd2e4-2ca5-4e2a-9fea-13373f910f34 (opens source in a new tab)
Ferric label
Version not recorded · Effective date not recorded
Ferric citrate decreased the relative bioavailability of concomitantly administered ciprofloxacin by approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aadd18e0-3752-11e4-8510-0800200c9a66 (opens source in a new tab)
Ferric label
Version not recorded · Effective date not recorded
Auryxia decreased the relative bioavailability of concomitantly administered ciprofloxacin by approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e8396fa-288b-402e-82b0-b1007d1b571f (opens source in a new tab)
Ferric label
Version not recorded · Effective date not recorded
Ferric citrate tablets decreased the relative bioavailability of concomitantly administered ciprofloxacin by approximately 45%.
Projected row 600
- Medicine slug
- ferric-carboxymaltose
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 4
- Source count
- 4
- Agreement rate
- 1
- Recorded readings
7 to 12 hours
- Numeric value
- 7
- Unit
- hours
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6a5cd2d-86bd-4042-974f-46e14d65fc2d (opens source in a new tab)
Ferric Carboxymaltose label
Version not recorded · Effective date not recorded
The iron injected or infused was rapidly cleared from the plasma, the terminal half-life ranged from 7 to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:517b4a19-45b3-4286-9f6a-ced4e10447de (opens source in a new tab)
Ferric Carboxymaltose label
Version not recorded · Effective date not recorded
The iron injected or infused was rapidly cleared from the plasma, the terminal half-life ranged from 7 to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bfdf7447-62e4-48ca-b903-11cb3b211064 (opens source in a new tab)
Ferric Carboxymaltose label
Version not recorded · Effective date not recorded
The iron injected or infused was rapidly cleared from the plasma, the terminal half-life ranged from 7 to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e8e95f4-8d3a-4658-9f6c-09edf2210341 (opens source in a new tab)
Ferric Carboxymaltose label
Version not recorded · Effective date not recorded
The iron injected or infused was rapidly cleared from the plasma, the terminal half-life ranged from 7 to 12 hours.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=590Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.